Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for major depression in cardiovascular patients after PCI or CABG
IRCT20090117001556N132Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pentoxifylline in major depressive disorder (MDD) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Severity of depression. Started Sep 2020; status: completed.
02
Drugs
pentoxifylline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT20090117001556N132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090117001556N132.